The 2013 American Cancer Society report provides an overview of breast cancer statistics in the United States, including incidence, mortality, survival, and screening data. It estimates 232,340 new invasive breast cancer cases and 39,620 deaths among U.S. women in 2013. One in eight women will develop breast cancer in their lifetime. Breast cancer incidence rates increased slightly among African American women, decreased among Hispanic women, and remained stable among other groups from 2006 to 2010. White women historically had the highest incidence rates, but rates are converging with African American women, especially in the 50-59 age group. Estrogen receptor-positive (ER+) breast cancer incidence increased in younger white women, Hispanic women aged 60-69, and most African American women, while ER-negative (ER-) breast cancer declined in most groups. Breast cancer death rates have dropped by 34% since 1990, but survival disparities persist, with African American women having the poorest survival. Continued efforts are needed to improve screening, diagnosis, and treatment for all populations. The report highlights racial and ethnic disparities in incidence and mortality, with African American women having higher death rates despite lower incidence. Survival rates vary by race and ethnicity, with African American women having the lowest 5-year survival rate. State variations in mammography screening prevalence, incidence, and mortality rates are also discussed, with higher screening rates correlating with lower rates of late-stage diagnoses. The report emphasizes the importance of early detection, consistent follow-up, and high-quality treatment to improve outcomes. Strategies to reduce breast cancer risk include avoiding weight gain, regular physical activity, and minimizing alcohol intake. Chemoprevention options like tamoxifen and raloxifene are recommended for high-risk individuals. Continued progress in breast cancer control requires sustained efforts to ensure equitable access to screening and treatment for all populations.The 2013 American Cancer Society report provides an overview of breast cancer statistics in the United States, including incidence, mortality, survival, and screening data. It estimates 232,340 new invasive breast cancer cases and 39,620 deaths among U.S. women in 2013. One in eight women will develop breast cancer in their lifetime. Breast cancer incidence rates increased slightly among African American women, decreased among Hispanic women, and remained stable among other groups from 2006 to 2010. White women historically had the highest incidence rates, but rates are converging with African American women, especially in the 50-59 age group. Estrogen receptor-positive (ER+) breast cancer incidence increased in younger white women, Hispanic women aged 60-69, and most African American women, while ER-negative (ER-) breast cancer declined in most groups. Breast cancer death rates have dropped by 34% since 1990, but survival disparities persist, with African American women having the poorest survival. Continued efforts are needed to improve screening, diagnosis, and treatment for all populations. The report highlights racial and ethnic disparities in incidence and mortality, with African American women having higher death rates despite lower incidence. Survival rates vary by race and ethnicity, with African American women having the lowest 5-year survival rate. State variations in mammography screening prevalence, incidence, and mortality rates are also discussed, with higher screening rates correlating with lower rates of late-stage diagnoses. The report emphasizes the importance of early detection, consistent follow-up, and high-quality treatment to improve outcomes. Strategies to reduce breast cancer risk include avoiding weight gain, regular physical activity, and minimizing alcohol intake. Chemoprevention options like tamoxifen and raloxifene are recommended for high-risk individuals. Continued progress in breast cancer control requires sustained efforts to ensure equitable access to screening and treatment for all populations.